About the Professors

Research interests and scholarly activities

• Efficacy of psychotherapy
• Risk factors for anxiety and depression
• Mindfulness, spirituality, and positive psychology
• Genetic and biological basis of anxiety and depression

Teaching fields

Educational Counselling concentration of M.Ed. program

• Theories of Counselling and Psychotherapy
• Supervision in Counselling
• Counselling Skills for Teachers

Selected Publications

Chapters in Books:

Koszycki D. La terapia interpersonale per il trattamento della depresione (2006). In Molinari E, Compare A, Paratii. Italian Handbook of Clinical Psychology and Heart Disease, Spring-Verlag, Milan. Pp 291-316

Koszycki D. (2006). Interpersonal psychotherapy for depression in patients with coronary heart disease. In, Molinari E, Compare A, Parati G(Eds). Clinical Psychology and Heart Disease. Springer Publisher. pp 369-390.

Papers in Refereed Journals:

Koszycki D, Raab K, Aldosary F, Bradwejn J. Efficacy of a spiritually-based intervention for generalized anxiety disorder: A pilot randomized trial. Journal of Clinical Psychology. In Press.

X ie R, He G, Koszycki D, Walker M, Wen SW. Fetal gender, social support, and postpartum depression. Canadian Journal of Psychiatry. 19:637-643, 2009.

Xie R, He G, Koszycki D, Walker M, Wen SW. Prenatal social support, postnatal social support, and postpartum depression. American Journal of Epidemiology. 19:637-643, 2009.

Koszycki D, Benger M, Shlik J, Bradwejn J. Randomized trial of cognitive behaviour therapy and mindfulness-based stress reduction in generalized social anxiety disorder. Behaviour Research and Therapy. 45:2518-2526, 2007.

Lespérance, F, Frasure-Smith N, Koszycki D, Laliberté M-A, van Zyl L, Baker B, Swenson JR, Ghatavi K, Abramson BL, Dorian P, Guertin M-C. Effects of citalopram and interpersonal pychotherapy in coronary artery disease patients. The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE). Journal of the American Medical Association. 297:367-412, 2007.

Wijeweera P, Arnason JT, Koszycki D, Merali Z. Evaluation of anxiolytic properties of Gotukola- (Centella asiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine. 13:668-76, 2006.

Rothe C, Koszycki D, Bradwejn J, King N, Deluca V. Tharmalingam S, Macciardi F, Deckert J, Kennedy J. Association of the Val 158 Met Catechol O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology. 31: 2237-2242, 2006.

Tharmalingam S, King N, De Luca V, Rothe C, Koszycki D, Bradwejn J, Macciardi F, Kennedy JL. Investigation of the Corticotropin-Releasing Hormone Receptor 2 Gene in Panic Disorder. Psychiatric Genetics 2006 16:93-97, 2006.

Frasure-Smith N, Koszycki D, Swenson JR, Baker B, van Zyl LT, Laliberté M-A, Abramson BL, Lamber J, Gravel G, Lespérance F (2006). CREATE (Canadian cardiac Randomized Evaluation of Antidepressant and psychotherapy Efficacy): Design and rationale for a randomized, controlled trial of interpersonal psychtherapy and citalopram for depression in coronary artery disease. Psychosomatic Medicine, 68:87-93, 2006.

Koszycki D, Torres S, Swain J, Bradwejn J. Central cholecystokinin activity in irritable bowel syndrome, panic disorder and normal controls. Psychosomatic Medicine, 67: 590-594, 2005.

Foot M, Koszycki D. Gender differences in anxiety-related traits in patients with panic disorder. Anxiety and Depression, 20:123-130, 2004.

Kaztman M, Koszycki D, Bradwejn J. Effects of CCK -tetrapeptide in patients with social phobia and obsessive compulsive disorder. Anxiety and Depression , 20:51-58, 2004.

Koszycki D, Lafontaine S, Frasure-Smith N, Swenson R, Lespérance F. Open trial of interpersonal psychotherapy, with or without medication, in depressed patients with coronary disease. Psychosomatics.45:319-324, 2004.

Rothe C, Koszycki D, Bradwejn J, King N, De Luca V, Shaikh S, Franke P, Garristen H, Fritze J, Kennedy JL.Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany. Neuroscience Letter, 363:276-279, 2004.

Koszycki D, Copen J, Bradwejn J. Sensitivity to CCK -4 in major depression. Journal of Affective Disorders, 80: 285-290, 2004.

Papers in Refereed Conference Proceedings:

Prichard Z, Bradwejn J, Kennedy JL, Xia X, Koszycki D (2009, November). Population genetic analysis of an association study of the cholecystokinin-B receptor gene with personality traits. XVII World Congress of Psychiatric Genetics, San Diego, California

Koszycki D, Bradwejn J(2009, June). Personality and clinical correlates of response to a laboratory stressor in patients with social anxiety disorder. World Congress of Biological Psychiatry, Paris, France.

Koszycki D, Raab K, Aldosary F, Bradwejn J (2009 May). Randomized trial of a spiritually-based intervention of generalized anxiety disorder: A pilot study. Annual Meeting of the American Psychiatric Association, San Francisco, California.

• Koszycki D. (2007, November) Mindfulness Meditation as a Treatment for Anxiety Disorders: An efficacy study in generalized social anxiety disorder (as part of a symposium on Alternative and Complementary Treatments for Mood and Anxiety Disorders sponsored by CANMAT). Presented at the Annual Meeting of the Canadian Psychiatric Association, Montreal, Canada.
• Koszycki D, Rothe C, Shlik J, Kennedy J, Bradwejn J. (2007, October). The influence of CCK -B receptor polymorphism and personality on panicogenic sensitivity to CCK -4 in healthy volunteers . Presented at the World Congress Psychiatric Genetics. , New York City , New York .

Di Guilio G, Zwanzger P, Koszycki D. (2007, June). Parental bonding in children at risk for panic disorder. Presented at the Annual Meeting of the Canadian Psychological Association Meeting, Ottawa, Canada.

Koszycki D, Raab K. (2007, May). The use of a spiritually-based therapy for the treatment of generalized anxiety disorder. Presented at the 3 rd International Conference on Spirituality and Mental Health, Ottawa, Canada.

Chan E, Zaremba E, Bradwejn J, Koszycki D. (2007, January). Impact of extraversion on the clinical profile of panic disorder. Presented at the 8 th Annual Meeting of the Society for Personality and Social Psychology, Memphis , Tenneesse.

• Gi Giulio G, Zwanzger P, Koszycki D. (2006, December). A comparative analysis of parental bonding in children of parents with panic disorder vs healthy control. Presented at Research Day, Department of Psychiatry, University of Ottawa , Canada .
• Van Zyl LT, Frasure-Smith N, Lesperance F, Koszycki D, Serebruany V. (2006, November). Treatment of major depression in coronary artery disease: results from the CREATE trial. Presented at the meeting of the Canadian Psychiatric Association, Toronto, Canada.

Bradwejn J, Koszycki D. (2006, October). CCK in psychiatric disorder .Presented at theBenzon Symposium No. 53. The New Biology of the Gastrin-Cholecystokinin Family of Hormones, Copenhagen, Denmark.

Bradwejn J, Koszycki D, Segal Z. (2006, October). Randomized controlled trial of acute and extension treatment with sertraline and self-administered cognitive behaviour therapy, alone or in combination, in panic disorder. Presented at the Meeting of the European College of Neuropsychopharmacology, Amsterdam , The Netherlands .

Koszycki D. CREATE study. (2006, September). Results of the IPT and clinical management comparisons. Presented at the European Conference on Psychosomatic Medicine, Dubrovnik, Croatia.

Koszycki D, Shlik J, Bradwejn J. (2006, March). Personality correlates of response to low dose CCK -4 in healthy volunteers. Presented at the Meeting of the American Society for Psychosomatic Medicine, Denver Colorado.

Koszycki D, Zwanzger P, Merali Z, Bradwejn J. (2005, March ) Heart rate variability and cortisol response to a stressor in children at high and low genetic risk for panic disorder. Presented at the Meeting of the American Society for Psychosomatic Medicine. Vancouver , Canada .

Tharmalingam S, King N, Rothe C, Koszycki D, Bradwejn J, Macciardi F, Kennedy J. (2004, October). Association between the C-45T polymorphism of the cholecystokinin gene and panic disorder. Presented at the Meeting of the American Society of Human Genetics, Toronto., Canada.

Koszycki D, Zwanzger P, Merali Z, Bradwejn J. (2004, June). Heart rate variability and cortisol response to a stressor in children at high and low genetic risk for panic disorder. Presented at the Colleguim Internationale Neuropsychopharmacologicum Congress, Paris, France.

Koszycki D, Lafontaine S, Frasure-Smith N, Swenson R, Lespérance F. (June, 2004) Open trial of interpersonal psychotherapy, with or without medication, in depressed patients with coronary disease. Presented at the International Meeting on Interpersonal Psychotherapy, Pittsburgh, Pennsylvania.

Bradwejn J, Koszycki D, Segal Z. (2003, May). Efficacy of Self-Administered Cognitive Behaviour Therapy and Sertraline in Panic Disorder. Presented at the Meeting of the American Psychiatric Association, San Franciso, California.